These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 2116260

  • 1. Pharmacokinetics and pharmacodynamics of pravastatin alone and with cholestyramine in hypercholesterolemia.
    Pan HY, DeVault AR, Swites BJ, Whigan D, Ivashkiv E, Willard DA, Brescia D.
    Clin Pharmacol Ther; 1990 Aug; 48(2):201-7. PubMed ID: 2116260
    [Abstract] [Full Text] [Related]

  • 2. Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II.
    Arch Intern Med; 1993 Jun 14; 153(11):1321-9. PubMed ID: 8507122
    [Abstract] [Full Text] [Related]

  • 3. Once-daily pravastatin in patients with primary hypercholesterolemia: a dose-response study.
    Jones PH, Farmer JA, Cressman MD, McKenney JM, Wright JT, Proctor JD, Berkson DM, Farnham DJ, Wolfson PM, Colfer HT.
    Clin Cardiol; 1991 Feb 14; 14(2):146-51. PubMed ID: 1904333
    [Abstract] [Full Text] [Related]

  • 4. Effect of pravastatin, an HMG CoA reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by their apolipoprotein composition.
    Bard JM, Parra HJ, Douste-Blazy P, Fruchart JC.
    Metabolism; 1990 Mar 14; 39(3):269-73. PubMed ID: 2106607
    [Abstract] [Full Text] [Related]

  • 5. [Pravastatin, cholestyramine and gemfibrozil in long-term therapy of primary hypercholesterolemia. An open randomized comparative study].
    Ditschuneit HH, Dreyer M, Dammann HG, Ditschuneit H.
    Med Klin (Munich); 1991 Mar 15; 86(3):142-8. PubMed ID: 1903497
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of pravastatin in patients with primary hypercholesterolemia. II. Once-daily versus twice-daily dosing.
    Hunninghake DB, Mellies MJ, Goldberg AC, Kuo PT, Kostis JB, Schrott HG, Insull W, Pan HY.
    Atherosclerosis; 1990 Dec 15; 85(2-3):219-27. PubMed ID: 2129319
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of familial hypercholesterolaemia: a controlled trial of the effects of pravastatin or cholestyramine therapy on lipoprotein and apolipoprotein levels.
    Wiklund O, Angelin B, Fager G, Eriksson M, Olofsson SO, Berglund L, Lindén T, Sjöberg A, Bondjers G.
    J Intern Med; 1990 Sep 15; 228(3):241-7. PubMed ID: 2119417
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of primary hypercholesterolaemia with pravastatin: efficacy and safety over three years.
    Simons LA, Nestel PJ, Clifton P, Janus ED, Simons J, Parfitt A.
    Med J Aust; 1992 Nov 02; 157(9):584-9. PubMed ID: 1406416
    [Abstract] [Full Text] [Related]

  • 12. [Comparison of the effectiveness of the HMG-CoA-reductase inhibitors pravastatin versus colestyramine in hypercholesteremia].
    Schwartzkopff W, Bimmermann A, Schleicher J.
    Arzneimittelforschung; 1990 Dec 02; 40(12):1322-7. PubMed ID: 2128866
    [Abstract] [Full Text] [Related]

  • 13. Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol.
    Reihnér E, Rudling M, Ståhlberg D, Berglund L, Ewerth S, Björkhem I, Einarsson K, Angelin B.
    N Engl J Med; 1990 Jul 26; 323(4):224-8. PubMed ID: 2114543
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Short- and long-term effects of lovastatin and pravastatin alone and in combination with cholestyramine on serum lipids, lipoproteins and apolipoproteins in primary hypercholesterolaemia.
    Jacob BG, Möhrle W, Richter WO, Schwandt P.
    Eur J Clin Pharmacol; 1992 Jul 26; 42(4):353-8. PubMed ID: 1516599
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics and pharmacodynamics of pravastatin in pediatric and adolescent cardiac transplant recipients on a regimen of triple immunosuppression.
    Hedman M, Neuvonen PJ, Neuvonen M, Holmberg C, Antikainen M.
    Clin Pharmacol Ther; 2004 Jan 26; 75(1):101-9. PubMed ID: 14749696
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.